Tarsus Pharmaceuticals, Inc. TARS Total Carrying Value of Debt
Total Carrying Value of Debt at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtInstrumentCarryingAmount.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s total carrying value of debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s total carrying value of debt?
- Tarsus Pharmaceuticals, Inc. (TARS) reported total carrying value of debt of $75M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s total carrying value of debt changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s total carrying value of debt decreased by 0.0% year-over-year, from $75M to $75M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s total carrying value of debt?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s total carrying value of debt has grown at a 55.4% compound annual growth rate (CAGR), from $20M to $75M.